China
Japan

China
Japan

China
Japan

My Privacy Preferences

Global Locations

275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300

2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170

^© 2000-2023. Parexel International Corporation.

Decentralized Clinical Trials

The future of clinical trials is now

See our new video spotlighting a patient’s perspective on the positive impact Decentralized Clinical Trials can have on daily life.

Changing what’s possible today for a future for patients tomorrow

Whatever challenges the world may throw at us — now, and tomorrow, Parexel’s Decentralized Clinical Trials represent an opportunity to rethink the traditional clinical trial model and refresh how research studies are conducted, while keeping the patient at the heart of this emerging paradigm. Developed within our Patient Innovation Center, our flexible Decentralized Clinical Trials solutions provide both fully virtual trials and hybrid options.

Leading the industry by engaging patients in Decentralized Clinical Trials

Our experience includes more than 250+ Decentralized Clinical Trials (inclusive of home nursing visits) and experience in excess of 200 remote patient engagement strategies incorporated into trials (e.g., patient recruitment and retention platforms, e-visits/video dosing regimens and patient insight projects).

This allows us to manage and deliver a wide range of fully virtual and hybrid approaches to Decentralized Clinical Trials while also offering important supporting capabilities:

	250+ DCTs (fully virtual and hybrid approaches including home nursing)
	200+ remote patient engagement strategies
	250+ direct-to-patient shipments
	300+ patient apps/eCOA platforms

Bringing it all together to enhance the patient experience

Our Decentralized Clinical Trial solutions combine in-house expertise and patient/caregiver insights with the latest technologies to create bespoke strategies to guide you through all aspects of planning, operationalizing, and safely deploying Decentralized Clinical Trials.

Together, we can help ensure that treatments get to the patients who need them most by making it easier for diverse populations in various geographies to access and enroll in research.

Working with your team, Parexel offers:

A proven track record of successfully implementing both hybrid and fully virtual approaches
An integrated, cross-functional team armed with experience, innovations, access to “best-in-breed” technologies, and processes in place to help you plan, operationalize and safely deploy Decentralized Clinical Trials
Access to our Patient Innovation Center, an invaluable resource that leverages patient advisory boards for global perspectives and applies its Patient Insights methodology to design clinical trials
Regulatory advice based on the latest guidance for your targeted region
Technology experts to advise on the right devices, patient sensors, and applications for integration into your study

Decentralized Clinical Trials and Patient Needs

Trishna Bharadia shares her daily living experience managing multiple sclerosis with Parexel’s Rosamund Round, Vice President, Patient Innovation Center and Amanda Knaggs, Senior Recruitment and Alliance Site Manager. They discuss the evolution toward decentralized clinical trials and the impact that would have on a patient like Trishna’s ability and willingness to participate in a clinical study.

Read the transcript

Trishna Bharadi...: I lead a really busy life. I work as a translator and analyst for a business intelligence company, and on top of that, I'm managing my MS, I'm managing the other conditions that I live with.

Trishna Bharadi...: To have taken part in the trials that I have been offered, it would have involved basically too much travel, too much time, too much burden on my family because I rely very heavily on my parents, particularly if I need to be taken to places. There's no point in taking part in something which is then potentially going to make you feel exhausted, or it's going to have a burden on your finances.

Rosamund Round: And I think that's one of the things that makes it so exciting working in the area of decentralized trials is that both we ask patients what they want, but we can use technology to make patient's lives easier.

Trishna Bharadi...: Sure.

Rosamund Round: Things like sensors for example, where patients don't have to actively go and have a test they just wear a watch for example, an actigraphy device, or we can use video calls with site stuff so you don't have to spend all that time traveling.

Amanda Knaggs: Decentralized trials I think will really help to improve the patient recruitment. And most importantly as well the retention of the patients that have rolled on to studies.

Trishna Bharadi...: You've raised a really good point there because it's one thing getting somebody to take part in a trial in the first place, but it's something completely different to keep them in the trial.

Amanda Knaggs: It's a partnership between the medical research organizations and the patients themselves.

Trishna Bharadi...: From my understanding there can be trials where everything is very virtual and technological, but then there's others which aren't so much. Is it possible to have a mixture of the two, or does it have to be one or the other?

Rosamund Round: There's basically a spectrum of how virtual you want to make a trial. So traditional is obviously at one end, fully virtual or fully decentralized is at the other end, and that's when the patient never even pops a toe into a site, everything's done for them in the home. And then you've got different shades in between. And we take a look at what physically has to be done at the site. So an MRI scan or a lumbar puncture needs to be done at site. Some of the simpler things can be done at home. So questionnaires and blood draws, that kind of thing, the patient doesn't need to come into the site for it.

Amanda Knaggs: So I think the site staff are really keen to learn and adopt these technologies because the accuracy of the data that is captured is much better now than in the past.

Rosamund Round: I know you've said that fitting a traditional clinical trial into your life could be quite challenging, but if some of that could be done in the home do you think that that would enable you to maybe take part in a trial?

Trishna Bharadi...: Definitely, definitely. Because I could just say, okay, the nurse is going to come at 10:00, I could say to my boss, okay, between 10:00 and 10:15 you won't see me online. And it would mean that I could spend more time with my parents in a way that isn't just about the caring aspect, it's about allowing me and my family to live our lives the way we want to live them.

Moving to another level of site collaboration

Parexel was recently recognized for its high-quality service by CenterWatch in its Global Clinical Trial Site Relationship Benchmark Survey. Parexel ranked one of the top three CROs among attributes most valued by sites and received “Excellent” ratings on many key performance attributes, including:

Well-trained monitors/clinical research associates (CRAs)
Organization and preparedness
Easily accessible staff maintaining open communication

As sponsors continue bringing many components of studies directly to patients in their homes and in their communities, Parexel seamlessly collaborates with sites to make the process as efficient as possible. As a pioneer in Decentralized Clinical Trial design and delivery, Parexel may offer sites more study opportunities, wider access to diverse patient populations in their region and reduced dropout rates due to remote patient engagement options. In turn, Parexel can design more effective protocols based on valuable site input about their patients. And together, Parexel and our site partners are even better poised to improve the overall study design experience for patients and sponsors.

We are always available for a conversation.

Submitting...

First Name

Last Name

Title

Company

Email Address

Country

Comments

Communication Preference

Yes, I would like to receive marketing communications including industry insights and trends from Parexel International.

Communication Preference

I would like to receive marketing communications from Parexel and consent to the processing of the personal data that I provide in accordance with and as described in the Privacy Policy.

Accept Decline